Literature DB >> 9717842

Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressor.

S H Hong1, C W Wong, M L Privalsky.   

Abstract

Nuclear hormone receptors are hormone-regulated transcription factors that bind to specific sites on DNA and modulate the expression of adjacent target genes. Many nuclear hormone receptors display bimodal transcriptional properties; thyroid hormone receptors, for example, typically repress target gene expression in the absence of hormone, but activate target gene expression in the presence of hormone. The ability to repress is closely linked to the ability of the apo-receptor to physically bind to auxiliary corepressor proteins denoted SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) and N-CoR (nuclear receptor corepressor), which, in turn, help mediate the actual molecular events involved in transcriptional silencing. We report here that repression by thyroid hormone receptors can be regulated not only by cognate hormone, but also by certain tyrosine kinase signal transduction pathways, such as that represented by the epidermal growth factor-receptor. Activation of tyrosine kinase signaling leads to inhibition of T3R-mediated repression with relatively little effect on activation. These effects appear to be mediated by a kinase-initiated disruption of the ability of T3R to interact with SMRT corepressor. Intriguingly, tyrosine kinase signaling similarly disrupted the interactions of SMRT with v-Erb A, with retinoic acid receptors, and with PLZF, a nonreceptor transcriptional repressor. We conclude that tyrosine kinase signaling exerts potentially important regulatory effects on transcriptional silencing mediated by a variety of transcription factors that operate through the SMRT corepressor complex.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9717842      PMCID: PMC2653426          DOI: 10.1210/mend.12.8.0160

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  64 in total

1.  SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia.

Authors:  S H Hong; G David; C W Wong; A Dejean; M L Privalsky
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

2.  Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein.

Authors:  P Dhordain; O Albagli; R J Lin; S Ansieau; S Quief; A Leutz; J P Kerckaert; R M Evans; D Leprince
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

3.  A conformational switch in nuclear hormone receptors is involved in coupling hormone binding to corepressor release.

Authors:  B C Lin; S H Hong; S Krig; S M Yoh; M L Privalsky
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

Review 4.  What's up and down with histone deacetylation and transcription?

Authors:  M J Pazin; J T Kadonaga
Journal:  Cell       Date:  1997-05-02       Impact factor: 41.582

5.  Stoichiometric and steric principles governing repression by nuclear hormone receptors.

Authors:  I Zamir; J Zhang; M A Lazar
Journal:  Genes Dev       Date:  1997-04-01       Impact factor: 11.361

6.  Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT).

Authors:  H Shibata; Z Nawaz; S Y Tsai; B W O'Malley; M J Tsai
Journal:  Mol Endocrinol       Date:  1997-06

7.  Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen.

Authors:  C L Smith; Z Nawaz; B W O'Malley
Journal:  Mol Endocrinol       Date:  1997-06

8.  The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT.

Authors:  T A Jackson; J K Richer; D L Bain; G S Takimoto; L Tung; K B Horwitz
Journal:  Mol Endocrinol       Date:  1997-06

9.  Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor.

Authors:  M D Krstic; I Rogatsky; K R Yamamoto; M J Garabedian
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

10.  Differential phosphorylation of chicken progesterone receptor in hormone-dependent and ligand-independent activation.

Authors:  W Bai; B G Rowan; V E Allgood; B W O'Malley; N L Weigel
Journal:  J Biol Chem       Date:  1997-04-18       Impact factor: 5.157

View more
  19 in total

1.  The SMRT corepressor is a target of phosphorylation by protein kinase CK2 (casein kinase II).

Authors:  Y Zhou; W Gross; S H Hong; M L Privalsky
Journal:  Mol Cell Biochem       Date:  2001-04       Impact factor: 3.396

2.  The SMRT corepressor is regulated by a MEK-1 kinase pathway: inhibition of corepressor function is associated with SMRT phosphorylation and nuclear export.

Authors:  S H Hong; M L Privalsky
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  SMRT and N-CoR corepressors are regulated by distinct kinase signaling pathways.

Authors:  Brian A Jonas; Martin L Privalsky
Journal:  J Biol Chem       Date:  2004-10-18       Impact factor: 5.157

4.  Heterodimers of retinoic acid receptors and thyroid hormone receptors display unique combinatorial regulatory properties.

Authors:  Sangho Lee; Martin L Privalsky
Journal:  Mol Endocrinol       Date:  2005-01-13

Review 5.  Cell signaling and nuclear receptors: new opportunities for molecular pharmaceuticals in liver disease.

Authors:  Jeff L Staudinger; Kristin Lichti
Journal:  Mol Pharm       Date:  2007-12-27       Impact factor: 4.939

Review 6.  Emerging roles of the corepressors NCoR1 and SMRT in homeostasis.

Authors:  Adrienne Mottis; Laurent Mouchiroud; Johan Auwerx
Journal:  Genes Dev       Date:  2013-04-15       Impact factor: 11.361

7.  The interaction between nuclear receptor corepressor and histone deacetylase 3 regulates both positive and negative thyroid hormone action in vivo.

Authors:  Seo-Hee You; Xiaohui Liao; Roy E Weiss; Mitchell A Lazar
Journal:  Mol Endocrinol       Date:  2010-04-28

Review 8.  Deconstructing repression: evolving models of co-repressor action.

Authors:  Valentina Perissi; Kristen Jepsen; Christopher K Glass; Michael G Rosenfeld
Journal:  Nat Rev Genet       Date:  2010-02       Impact factor: 53.242

9.  Wnt5a controls Notch1 signaling through CaMKII-mediated degradation of the SMRT corepressor protein.

Authors:  Eun-Jung Ann; Hwa-Young Kim; Mi-Sun Seo; Jung-Soon Mo; Mi-Yeon Kim; Ji-Hye Yoon; Ji-Seon Ahn; Hee-Sae Park
Journal:  J Biol Chem       Date:  2012-08-10       Impact factor: 5.157

10.  New insights into the functions and regulation of the transcriptional corepressors SMRT and N-CoR.

Authors:  Kristopher J Stanya; Hung-Ying Kao
Journal:  Cell Div       Date:  2009-04-21       Impact factor: 5.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.